SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-252748
Filing Date
2012-05-30
Accepted
2012-05-30 12:37:38
Documents
3
Period of Report
2012-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d359382d8k.htm 8-K 30677
2 AMENDED AND RESTATED BYLAWS OF GALECTIN THERAPEUTICS INC. d359382dex31.htm EX-3.1 92881
3 RESTATED ARTICLES OF INCORPORATION OF GALECTIN THERAPEUTICS INC. d359382dex32.htm EX-3.2 12485
  Complete submission text file 0001193125-12-252748.txt   137554
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 12876630
SIC: 2834 Pharmaceutical Preparations